Literature DB >> 22204375

Potential pathogenic inflammatory mechanisms of endothelial dysfunction induced by type 2 diabetes mellitus.

Anna-Maria Kampoli1, Dimitris Tousoulis, Alexandros Briasoulis, George Latsios, Nikolaos Papageorgiou, Christodoulos Stefanadis.   

Abstract

Insulin resistance and the vascular complications of diabetes include activation of the inflammation cascade, endothelial dysfunction, and oxidative stress. The comorbidities of diabetes, namely obesity, insulin resistance, hyperglycemia, hypertension and dyslipidemia collectively aggravate these processes while antihyperglycemic interventions tend to correct them. Increased C-reactive protein, interleukin 6, tumor necrosis factor alpha and especially interstitial cellular adhesion molecule-1, vascular cellular adhesion molecule-1, and E-selectin are associated with cardiovascular and non-cardiovascular complications of both type 1 and type 2 diabetes. We sought to review the clinical implications of the inflammation theory, including the relevance of inflammation markers as predictors of type 2 diabetes in clinical studies, and the potential treatments of diabetes, inferred from the pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22204375     DOI: 10.2174/138161211798764825

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  28 in total

1.  Diabetes-related alterations in the enteric nervous system and its microenvironment.

Authors:  Mária Bagyánszki; Nikolett Bódi
Journal:  World J Diabetes       Date:  2012-05-15

Review 2.  Type 2 diabetes and cardiovascular disease: what next?

Authors:  Joshua J Joseph; Sherita Hill Golden
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-04       Impact factor: 3.243

3.  Reducing CXCR4-mediated nociceptor hyperexcitability reverses painful diabetic neuropathy.

Authors:  Nirupa D Jayaraj; Bula J Bhattacharyya; Abdelhak A Belmadani; Dongjun Ren; Craig A Rathwell; Sandra Hackelberg; Brittany E Hopkins; Herschel R Gupta; Richard J Miller; Daniela M Menichella
Journal:  J Clin Invest       Date:  2018-04-23       Impact factor: 14.808

4.  LXR agonist modifies neuronal lipid homeostasis and decreases PGD2 in the dorsal root ganglia in western diet-fed mice.

Authors:  Nadia Elshareif; Chaitanya K Gavini; Virginie Mansuy-Aubert
Journal:  Sci Rep       Date:  2022-06-24       Impact factor: 4.996

Review 5.  The vascular neural network--a new paradigm in stroke pathophysiology.

Authors:  John H Zhang; Jerome Badaut; Jiping Tang; Andre Obenaus; Richard Hartman; William J Pearce
Journal:  Nat Rev Neurol       Date:  2012-10-16       Impact factor: 42.937

6.  Effects of percutaneous lower-extremity arterial interventions on endothelial function and inflammation response in patients with both type 2 diabetes and lower-extremity peripheral arterial disease.

Authors:  Yaping Du; Fujun Wang; Huiqing Qi; Haixia Ding; Lin Hou; Qian Gao; Miao Tan; Yueqin Liu; Na Xing; Jin Sun
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

7.  Perinatal systemic inflammatory responses of growth-restricted preterm newborns.

Authors:  T F McElrath; E N Allred; L Van Marter; R N Fichorova; A Leviton
Journal:  Acta Paediatr       Date:  2013-08-05       Impact factor: 2.299

8.  Anti-inflammatory mesenchymal stem cells (MSC2) attenuate symptoms of painful diabetic peripheral neuropathy.

Authors:  Ruth S Waterman; Jenny Morgenweck; Bobby D Nossaman; Anna E Scandurro; Sophia A Scandurro; Aline M Betancourt
Journal:  Stem Cells Transl Med       Date:  2012-07-09       Impact factor: 6.940

9.  Plasma Brain Natriuretic Peptide, Endothelin-1, and Matrix Metalloproteinase 9 Expression and Significance in Type 2 Diabetes Mellitus Patients with Ischemic Heart Disease.

Authors:  Chunfang Ju; Meixin Ye; Feng Li
Journal:  Med Sci Monit       Date:  2015-07-19

10.  COX-2-derived prostanoids and oxidative stress additionally reduce endothelium-mediated relaxation in old type 2 diabetic rats.

Authors:  Emilie Vessières; Anne-Laure Guihot; Bertrand Toutain; Maud Maquigneau; Céline Fassot; Laurent Loufrani; Daniel Henrion
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.